3D-bioprinted microenvironments shape the growth and IgG1 monoclonal antibody production of CHO DG44 cells
Abstract
Introduction: Three-dimensional (3D) bioprinting offers new possibilities to recreate in vivo-like microenvironments for mammalian cells, with potential applications in therapeutic bioproduction. Methods: In this study, we evaluate the growth, central carbon metabolism, and IgG1 monoclonal antibody (mAb) bioproduction of Chinese hamster ovary (CHO) DG44 cells embedded in 3D-bioprinted hydrogel constructs under different cultivation strategies: batch, semicontinuous, and both modes preceded by a 3D amplification step in an amplification medium. Results and Discussion: Across all 3D conditions, CHO DG44 cells exhibited markedly reduced and limited growth over 14 days, most likely due to restricted nutrient diffusion and limited available space imposed by the intrinsic porosity of the bioink. Glucose was not depleted under any condition. In semicontinuous cultures, glucose consumption and lactate production remained approximately constant over the full culture duration, whereas both processes stopped midrun in batch cultures. The relatively low overall glucose consumption indicates that higher cell-to-medium ratios could be implemented to improve nutrient utilisation. mAb production closely followed lactate metabolism, with sustained production in semicontinuous cultures and an early plateau in batch mode, resulting in 2- to 3-fold lower final mAb amounts in batch compared with semicontinuous cultures. Introducing a 3D amplification phase more than doubled cumulative mAb production after 14 days. Overall, low growth, low titres, low space-time yields, and residual nutrients in the supernatant show that the current 3D-bioprinting strategy is not yet optimal for mAb manufacturing. However, despite this apparent weakness of the 3D-bioprinted environment for production, the 3D specific productivity of 3D-amplified semicontinuous conditions was found to be higher than the global suspension specific productivity. Consequently, our data suggest that increasing the cell-to- medium ratio and reducing the construct size to mitigate diffusion limitations enhance cell-specific productivity and process efficiency in 3D-bioprinted CHO- based bioproduction systems.
Related
- IgM monoclonal antibodies reduce IgG-mediated antibody-dependent enhancement of Zika and dengue virus infectivity
- A Monoclonal Antibody Panel to Track Antigenic Evolution of SARS-CoV-2 JN.1 Subvariants
- Interaction with complement factor C1q can contribute to and improve monoclonal antibody-mediated protection against lethal HSV-1 challenge
- Monoclonal anti-dsRNA antibody-based metagenomics (MADAM) reveal Pyricularia oryzae mycovirome
- Cryo-EM and X-ray structures of an anti-MHC-I monoclonal antibody/H2-Kb complex reveal the basis of conformational dependence and allelic specificity
BibTeX
@article{cowles20263dbioprinted,
title = {{3D-bioprinted microenvironments shape the growth and IgG1 monoclonal antibody production of CHO DG44 cells}},
author = {Elliott Cowles and Laura Chastagnier and Lucie Essayan and Julia Niemann and Magali Barbaroux and Christophe Marquette and Emma Petiot},
journal = {Frontiers in Bioengineering and Biotechnology},
year = {2026},
month = sep,
doi = {10.3389/fbioe.2026.1854326},
url = {https://hal.science/hal-05774133v1},
note = {CC BY},
}
RIS
TY - JOUR
TI - 3D-bioprinted microenvironments shape the growth and IgG1 monoclonal antibody production of CHO DG44 cells
AU - Elliott Cowles
AU - Laura Chastagnier
AU - Lucie Essayan
AU - Julia Niemann
AU - Magali Barbaroux
AU - Christophe Marquette
AU - Emma Petiot
PY - 2026
DA - 2026/09/24
JO - Frontiers in Bioengineering and Biotechnology
DO - 10.3389/fbioe.2026.1854326
UR - https://hal.science/hal-05774133v1
AB - Introduction: Three-dimensional (3D) bioprinting offers new possibilities to recreate in vivo-like microenvironments for mammalian cells, with potential applications in therapeutic bioproduction. Methods: In this study, we evaluate the growth, central carbon metabolism, and IgG1 monoclonal antibody (mAb) bioproduction of Chinese hamster ovary (CHO) DG44 cells embedded in 3D-bioprinted hydrogel constructs under different cultivation strategies: batch, semicontinuous, and both modes preceded by a 3D amplification step in an amplification medium. Results and Discussion: Across all 3D conditions, CHO DG44 cells exhibited markedly reduced and limited growth over 14 days, most likely due to restricted nutrient diffusion and limited available space imposed by the intrinsic porosity of the bioink. Glucose was not depleted under any condition. In semicontinuous cultures, glucose consumption and lactate production remained approximately constant over the full culture duration, whereas both processes stopped midrun in batch cultures. The relatively low overall glucose consumption indicates that higher cell-to-medium ratios could be implemented to improve nutrient utilisation. mAb production closely followed lactate metabolism, with sustained production in semicontinuous cultures and an early plateau in batch mode, resulting in 2- to 3-fold lower final mAb amounts in batch compared with semicontinuous cultures. Introducing a 3D amplification phase more than doubled cumulative mAb production after 14 days. Overall, low growth, low titres, low space-time yields, and residual nutrients in the supernatant show that the current 3D-bioprinting strategy is not yet optimal for mAb manufacturing. However, despite this apparent weakness of the 3D-bioprinted environment for production, the 3D specific productivity of 3D-amplified semicontinuous conditions was found to be higher than the global suspension specific productivity. Consequently, our data suggest that increasing the cell-to- medium ratio and reducing the construct size to mitigate diffusion limitations enhance cell-specific productivity and process efficiency in 3D-bioprinted CHO- based bioproduction systems.
SN - 2296-4185
ER -